Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology. Regular features include articles describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future by leading authorities.
Gut will consider very high quality papers under the Fast Track Review scheme. This scheme relies on a dedicated group of top class reviewers to deliver a final decision on reviewed manuscripts within seven days. The scheme is free to authors; the journal donates money to charity for every completed manuscript.
Authors can choose to have their article published Open Access for a fee of £1,950 (plus applicable VAT). Authors can also choose to publish their article in colour for the print edition for a fee of £250.
Submission to Gut implies that the work described has not been accepted for publication elsewhere, that it is not under consideration for publication elsewhere and does not duplicate material already published.
For guidelines on submission and editorial policies for Gut please refer to the BMJ Author Hub. Here you will find information on planning your research through to submitting and promoting your research.
Please review the below specifications of each article type and the required article lengths, illustrations and table limits, and reference counts. The word count excludes the title page, abstract, tables, acknowledgements and contributions, and references unless stated otherwise. Manuscripts should be as succinct as possible.
Original research includes articles reporting original data (eg, controlled trials and intervention studies):
up to 4,000
up to 250 words: ‘Objective’, ‘Design’, ‘Results’, ‘Conclusion’
Figures are not limited, but must be thoroughly justified.
limited to those critical and relevant to the manuscript (around 50)
Authors should also complete a short summary ‘box’ after the abstract indicating the significance of this study using the below headings:
- What is already known about this subject?
- What are the new findings?
- How might it impact on clinical practice in the foreseeable future?
Leading articles are commissioned only.
Commentaries are commissioned only.
Gut rarely publishes Case reports unless they illustrate a significant advance in our understanding of disease aetiology or pathogenetic mechanisms.
up to 2,000
up to 200 words
up to 2
up to 15
Letters should be related to a recent article published in Gut. Original data may be included if it is relevant and gives added weight to the comment on the previously published article.
up to 600
up to 2
up to 4
GI snapshots report unusual images that make an educational point. Since the aim of these articles is to stimulate the reader to think about the case, the title should be ambiguous and not give away the final diagnosis immediately (e.g. “Recurrent vomiting in 90 year old female”).
GI snapshots have two parts:
- Introduction – a brief clinical introduction to a case (maximum 200 words) followed by an image and a question designed to stimulate the reader to think about what the image shows. The legend should not indicate the diagnosis but should simply describe the nature of the image (e.g. ‘endoscopic view of second part of duodenum’).
- Answer – appears later in the issue (maximum 200 words) outlines a brief description of the key diagnostic features of the image, the outcome, and a teaching point. GI snapshots will not include more than 5 references.
The quality of the image must be at least 300dpi and in TIFF, JPEG, GIF or EPS format. Videos are also welcome and should be in .mov, .avi, or .mpeg format.
Recent advances in basic science/recent advances in clinical practice
These are commissioned only articles.
Gut is willing to consider publishing supplements to regular issues. For more information on supplement proposal please see the BMJ Author Hub.